Objective: We present the first clinical report involving use of the Prismaflex (Gambro) with the newly developed Prismaflex HF20 Set in 200 consecutive treatments for patients with end-stage renal ...
The FDA has issued an early alert warning of a “potentially high-risk” device safety issue regarding the Prismaflex control units, manufactured by Vantive, noting that the sets may continue to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results